229 related articles for article (PubMed ID: 26209090)
1. Vitamin D and prostate cancer prognosis: a Mendelian randomization study.
Trummer O; Langsenlehner U; Krenn-Pilko S; Pieber TR; Obermayer-Pietsch B; Gerger A; Renner W; Langsenlehner T
World J Urol; 2016 Apr; 34(4):607-11. PubMed ID: 26209090
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D and mortality: a Mendelian randomization study.
Trummer O; Pilz S; Hoffmann MM; Winkelmann BR; Boehm BO; März W; Pieber TR; Obermayer-Pietsch B; Renner W
Clin Chem; 2013 May; 59(5):793-7. PubMed ID: 23319826
[TBL] [Abstract][Full Text] [Related]
3. Association of rs2282679 A>C polymorphism in vitamin D binding protein gene with colorectal cancer risk and survival: effect modification by dietary vitamin D intake.
Zhu Y; Wang PP; Zhai G; Bapat B; Savas S; Woodrow JR; Campbell PT; Li Y; Yang N; Zhou X; Dicks E; Mclaughlin JR; Parfrey PS
BMC Cancer; 2018 Feb; 18(1):155. PubMed ID: 29409465
[TBL] [Abstract][Full Text] [Related]
4. BCL2 genotypes and prostate cancer survival.
Renner W; Langsenlehner U; Krenn-Pilko S; Eder P; Langsenlehner T
Strahlenther Onkol; 2017 Jun; 193(6):466-471. PubMed ID: 28396899
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of vitamin D-binding protein and cancer risk.
Tagliabue E; Raimondi S; Gandini S
Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1758-65. PubMed ID: 26364161
[TBL] [Abstract][Full Text] [Related]
6. Using genetic proxies for lifecourse sun exposure to assess the causal relationship of sun exposure with circulating vitamin d and prostate cancer risk.
Bonilla C; Gilbert R; Kemp JP; Timpson NJ; Evans DM; Donovan JL; Hamdy FC; Neal DE; Fraser WD; Davey SG; Lewis SJ; Lathrop M; Martin RM
Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):597-606. PubMed ID: 23441100
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
[TBL] [Abstract][Full Text] [Related]
8. Impact of Vitamin D Binding Protein Levels on Alzheimer's Disease: A Mendelian Randomization Study.
Zhang H; Wang T; Han Z; Wang L; Zhang Y; Wang L; Liu G
J Alzheimers Dis; 2020; 74(3):991-998. PubMed ID: 32116251
[TBL] [Abstract][Full Text] [Related]
9. The Glu228Ala polymorphism in the ligand binding domain of death receptor 4 is associated with increased risk for prostate cancer metastases.
Langsenlehner T; Langsenlehner U; Renner W; Kapp KS; Krippl P; Hofmann G; Clar H; Pummer K; Mayer R
Prostate; 2008 Feb; 68(3):264-8. PubMed ID: 18163425
[TBL] [Abstract][Full Text] [Related]
10. The association of an elevated plasma fibrinogen level with cancer-specific and overall survival in prostate cancer patients.
Thurner EM; Krenn-Pilko S; Langsenlehner U; Stojakovic T; Pichler M; Gerger A; Kapp KS; Langsenlehner T
World J Urol; 2015 Oct; 33(10):1467-73. PubMed ID: 25475065
[TBL] [Abstract][Full Text] [Related]
11. Genetic variants in vitamin D pathway in Egyptian asthmatic children: a pilot study.
Ismail MF; Elnady HG; Fouda EM
Hum Immunol; 2013 Dec; 74(12):1659-64. PubMed ID: 24007655
[TBL] [Abstract][Full Text] [Related]
12. Genetic sequence variants in vitamin D metabolism pathway genes, serum vitamin D level and outcome in head and neck cancer patients.
Azad AK; Bairati I; Qiu X; Huang H; Cheng D; Liu G; Meyer F; Adjei A; Xu W
Int J Cancer; 2013 Jun; 132(11):2520-7. PubMed ID: 23169318
[TBL] [Abstract][Full Text] [Related]
13. An inherited variant in the gene coding for vitamin D-binding protein and survival from cutaneous melanoma: a BioGenoMEL study.
Davies JR; Field S; Randerson-Moor J; Harland M; Kumar R; Anic GM; Nagore E; Hansson J; Höiom V; Jönsson G; Gruis NA; Park JY; Guan J; Sivaramakrishna Rachakonda P; Wendt J; Pjanova D; Puig S; Schadendorf D; Okamoto I; Olsson H; Affleck P; García-Casado Z; Puig-Butille JA; Stratigos AJ; Kodela E; Donina S; Sucker A; Hosen I; Egan KM; Barrett JH; van Doorn R; Bishop DT; Newton-Bishop J
Pigment Cell Melanoma Res; 2014 Mar; 27(2):234-43. PubMed ID: 24219834
[TBL] [Abstract][Full Text] [Related]
14. The role of plasma microseminoprotein-beta in prostate cancer: an observational nested case-control and Mendelian randomization study in the European prospective investigation into cancer and nutrition.
Smith Byrne K; Appleby PN; Key TJ; Holmes MV; Fensom GK; Agudo A; Ardanaz E; Boeing H; Bueno-de-Mesquita HB; Chirlaque MD; Kaaks R; Larrañaga N; Palli D; Perez-Cornago A; Quirós JR; Ricceri F; Sánchez MJ; Tagliabue G; Tsilidis KK; Tumino R; Fortner RT; Ferrari P; ; Riboli E; Lilja H; Travis RC
Ann Oncol; 2019 Jun; 30(6):983-989. PubMed ID: 31089709
[TBL] [Abstract][Full Text] [Related]
15. Genetic variants in RhoA and ROCK1 genes are associated with the development, progression and prognosis of prostate cancer.
Liu K; Li X; Wang J; Wang Y; Dong H; Li J
Oncotarget; 2017 Mar; 8(12):19298-19309. PubMed ID: 28184030
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians.
Ma J; Stampfer MJ; Gann PH; Hough HL; Giovannucci E; Kelsey KT; Hennekens CH; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):385-90. PubMed ID: 9610787
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1, and CYP24A1, in prostate cancer.
Holick CN; Stanford JL; Kwon EM; Ostrander EA; Nejentsev S; Peters U
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1990-9. PubMed ID: 17932346
[TBL] [Abstract][Full Text] [Related]
18. Association of vitamin D receptor FokI polymorphism with prostate cancer risk, clinicopathological features and recurrence of prostate specific antigen after radical prostatectomy.
Huang SP; Huang CY; Wu WJ; Pu YS; Chen J; Chen YY; Yu CC; Wu TT; Wang JS; Lee YH; Huang JK; Huang CH; Wu MT
Int J Cancer; 2006 Oct; 119(8):1902-7. PubMed ID: 16708371
[TBL] [Abstract][Full Text] [Related]
19. DNA methyltransferase 3b (DNMT3b), tumor tissue DNA methylation, Gleason score, and prostate cancer mortality: investigating causal relationships.
Gillio-Tos A; Fiano V; Zugna D; Vizzini L; Pearce N; Delsedime L; Merletti F; Richiardi L
Cancer Causes Control; 2012 Sep; 23(9):1549-55. PubMed ID: 22810147
[TBL] [Abstract][Full Text] [Related]
20. Investigation of Interleukin-1β Polymorphisms in Prostate Cancer.
Yencilek F; Yildirim A; Yilmaz SG; Altinkilic EM; Dalan AB; Bastug Y; Isbir T
Anticancer Res; 2015 Nov; 35(11):6057-61. PubMed ID: 26504029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
